Package 72603-200-01

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72603-200-01
Digits Only 7260320001
Product NDC 72603-200
Product ID 72603-200_3d02b630-f667-47e6-b2d5-f7317b73df2e
Description

1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-200-01) / 25 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2019-05-29
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3d02b630-f667-47e6-b2d5-f7317b73df2e", "openfda": {"upc": ["0372603200010"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["ddf55319-bf62-4ec7-8be2-ef97188837c4"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-200-01)  / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72603-200-01", "marketing_start_date": "20190529"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "72603-200_3d02b630-f667-47e6-b2d5-f7317b73df2e", "dosage_form": "INJECTABLE, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "72603-200", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA203263", "marketing_category": "ANDA", "marketing_start_date": "20190529", "listing_expiration_date": "20261231"}